-
1
-
-
0037112184
-
Prognostic factors for relapse in stage i seminoma managed by surveillance: A pooled analysis
-
Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, et al., Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis. J Clin Oncol 2002;20:4448-4452
-
(2002)
J Clin Oncol
, vol.20
, pp. 4448-4452
-
-
Warde, P.1
Specht, L.2
Horwich, A.3
Oliver, T.4
Panzarella, T.5
Gospodarowicz, M.6
-
2
-
-
33845757611
-
Treatment options, prognostic factors and selection of treatment in stage i seminoma
-
Martin J, Chung P, Warde P. Treatment options, prognostic factors and selection of treatment in stage I seminoma. Onkologie 2006;29:592-598
-
(2006)
Onkologie
, vol.29
, pp. 592-598
-
-
Martin, J.1
Chung, P.2
Warde, P.3
-
3
-
-
38949169584
-
European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part i
-
Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008;53:478-496
-
(2008)
Eur Urol
, vol.53
, pp. 478-496
-
-
Krege, S.1
Beyer, J.2
Souchon, R.3
Albers, P.4
Albrecht, W.5
Algaba, F.6
-
5
-
-
0037504532
-
Cardiovascular disease as a long-term complication of treatment for testicular cancer
-
Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 2003;21:1513-1523
-
(2003)
J Clin Oncol
, vol.21
, pp. 1513-1523
-
-
Huddart, R.A.1
Norman, A.2
Shahidi, M.3
Horwich, A.4
Coward, D.5
Nicholls, J.6
-
6
-
-
33644835617
-
Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer
-
van den Belt-Dusebout AW, Nuver J, de Wit R, Gietema JA, ten Bokkel Huinink WW, Rodrigus PT, et al. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2006;24:467-475
-
(2006)
J Clin Oncol
, vol.24
, pp. 467-475
-
-
Van Den Belt-Dusebout, A.W.1
Nuver, J.2
De Wit, R.3
Gietema, J.A.4
Ten Bokkel Huinink, W.W.5
Rodrigus, P.T.6
-
7
-
-
0030966297
-
Risk of second malignant neoplasms among long-term survivors of testicular cancer
-
Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997;89:1429-1439
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 1429-1439
-
-
Travis, L.B.1
Curtis, R.E.2
Storm, H.3
Hall, P.4
Holowaty, E.5
Van Leeuwen, F.E.6
-
8
-
-
0027535136
-
Second cancer risk following testicular cancer: A follow-up study of 1,909 patients
-
van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, Noyon R, Eliel MR, van Kerkhoff EH, et al. Second cancer risk following testicular cancer: A follow-up study of 1,909 patients. J Clin Oncol 1993;11:415-424
-
(1993)
J Clin Oncol
, vol.11
, pp. 415-424
-
-
Van Leeuwen, F.E.1
Stiggelbout, A.M.2
Van Den Belt-Dusebout, A.W.3
Noyon, R.4
Eliel, M.R.5
Van Kerkhoff, E.H.6
-
9
-
-
0028354951
-
Mortality and cancer incidence following radiotherapy for seminoma of the testis
-
Horwich A, Bell J. Mortality and cancer incidence following radiotherapy for seminoma of the testis. Radiother Oncol 1994;30:193-198
-
(1994)
Radiother Oncol
, vol.30
, pp. 193-198
-
-
Horwich, A.1
Bell, J.2
-
10
-
-
0025220320
-
Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy
-
Fosså SD, Langmark F, Aass N, Andersen A, Lothe R, Børresen AL. Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 1990;61:639-643
-
(1990)
Br J Cancer
, vol.61
, pp. 639-643
-
-
Fosså, S.D.1
Langmark, F.2
Aass, N.3
Andersen, A.4
Lothe, R.5
Børresen, A.L.6
-
11
-
-
0031715844
-
Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer
-
Gyenes G, Rutqvist LE, Liedberg A, Fornander T. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 1998;48:185-190
-
(1998)
Radiother Oncol
, vol.48
, pp. 185-190
-
-
Gyenes, G.1
Rutqvist, L.E.2
Liedberg, A.3
Fornander, T.4
-
12
-
-
0025374837
-
Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry
-
Rutqvist LE, Johansson H. Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer 1990;61:866-868
-
(1990)
Br J Cancer
, vol.61
, pp. 866-868
-
-
Rutqvist, L.E.1
Johansson, H.2
-
13
-
-
0026715803
-
Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer
-
Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992;22:887-896
-
(1992)
Int J Radiat Oncol Biol Phys
, vol.22
, pp. 887-896
-
-
Rutqvist, L.E.1
Lax, I.2
Fornander, T.3
Johansson, H.4
-
14
-
-
0033026864
-
Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up
-
Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, van Putten WL, Levendag PC. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 1999;51:35-42.
-
(1999)
Radiother Oncol
, vol.51
, pp. 35-42
-
-
Reinders, J.G.1
Heijmen, B.J.2
Olofsen-Van Acht, M.J.3
Van Putten, W.L.4
Levendag, P.C.5
-
16
-
-
0028279135
-
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy
-
Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994;12:447-453
-
(1994)
J Clin Oncol
, vol.12
, pp. 447-453
-
-
Cuzick, J.1
Stewart, H.2
Rutqvist, L.3
Houghton, J.4
Edwards, R.5
Redmond, C.6
-
17
-
-
0023250362
-
Cardiac disease after mediastinal irradiation for seminoma
-
Lederman GS, Sheldon TA, Chaffey JT, Herman TS, Gelman RS, Coleman CN. Cardiac disease after mediastinal irradiation for seminoma. Cancer 1987;60:772-776
-
(1987)
Cancer
, vol.60
, pp. 772-776
-
-
Lederman, G.S.1
Sheldon, T.A.2
Chaffey, J.T.3
Herman, T.S.4
Gelman, R.S.5
Coleman, C.N.6
-
18
-
-
0026440522
-
Seminoma of the testis: Long-term beneficial and deleterious results of radiation
-
Hanks GE, Peters T, Owen J. Seminoma of the testis: Long-term beneficial and deleterious results of radiation. Int J Radiat Oncol Biol Phys 1992;24:913-919
-
(1992)
Int J Radiat Oncol Biol Phys
, vol.24
, pp. 913-919
-
-
Hanks, G.E.1
Peters, T.2
Owen, J.3
-
19
-
-
0008292789
-
Optimal planning target volume for stage i testicular seminoma: A Medical Research Council randomized trial
-
Fosså SD, Horwich A, Russell JM, Roberts JT, Cullen MH, Hodson NJ, et al. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. J Clin Oncol 1999;17:1146.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1146
-
-
Fosså, S.D.1
Horwich, A.2
Russell, J.M.3
Roberts, J.T.4
Cullen, M.H.5
Hodson, N.J.6
-
20
-
-
14544272797
-
Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage i Testicular Seminoma: A report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)
-
Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, et al. Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: A report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 2005;23:1200-1208
-
(2005)
J Clin Oncol
, vol.23
, pp. 1200-1208
-
-
Jones, W.G.1
Fossa, S.D.2
Mead, G.M.3
Roberts, J.T.4
Sokal, M.5
Horwich, A.6
-
21
-
-
22544476802
-
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage i seminoma: A randomized trial
-
Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: A randomized trial. Lancet 2005;366:293-300.
-
(2005)
Lancet
, vol.366
, pp. 293-300
-
-
Oliver, R.T.1
Mason, M.D.2
Mead, G.M.3
Von Der Maase, H.4
Rustin, G.J.5
Joffe, J.K.6
-
22
-
-
0030001271
-
Omission of the pelvic irradiation in stage i testicular seminoma: A study of postorchiectomy paraaortic radiotherapy
-
Kiricuta IC, Sauer J, Bohndorf W. Omission of the pelvic irradiation in stage I testicular seminoma: A study of postorchiectomy paraaortic radiotherapy. Int J Radiat Oncol Biol Phys 1996;35:293-298
-
(1996)
Int J Radiat Oncol Biol Phys
, vol.35
, pp. 293-298
-
-
Kiricuta, I.C.1
Sauer, J.2
Bohndorf, W.3
-
23
-
-
3042699830
-
Para-aortic irradiation for stage i testicular seminoma: Results of a prospective study in 675 patients: A trial of the German testicular cancer study group (GTCSG)
-
Classen J, Schmidberger H, Meisner C, Winkler C, Dunst J, Souchon R, et al. Para-aortic irradiation for stage I testicular seminoma: Results of a prospective study in 675 patients: A trial of the German testicular cancer study group (GTCSG). Br J Cancer 2004;90:2305-2311
-
(2004)
Br J Cancer
, vol.90
, pp. 2305-2311
-
-
Classen, J.1
Schmidberger, H.2
Meisner, C.3
Winkler, C.4
Dunst, J.5
Souchon, R.6
-
24
-
-
67651235907
-
NCCN clinical practice guidelines in oncology: Testicular cancer
-
Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, et al. NCCN clinical practice guidelines in oncology: Testicular cancer. J Natl Compr Canc Netw 2009;7:672-693
-
(2009)
J Natl Compr Canc Netw
, vol.7
, pp. 672-693
-
-
Motzer, R.J.1
Agarwal, N.2
Beard, C.3
Bolger, G.B.4
Boston, B.5
Carducci, M.A.6
-
25
-
-
0029117461
-
Stage i testicular seminoma: Results of adjuvant irradiation and surveillance
-
Warde P, Gospodarowicz MK, Panzarella T, Catton CN, Sturgeon JF, Moore M, et al. Stage I testicular seminoma: Results of adjuvant irradiation and surveillance. J Clin Oncol 1995;13:2255-2262
-
(1995)
J Clin Oncol
, vol.13
, pp. 2255-2262
-
-
Warde, P.1
Gospodarowicz, M.K.2
Panzarella, T.3
Catton, C.N.4
Sturgeon, J.F.5
Moore, M.6
-
26
-
-
0027362639
-
Surveillance following orchidectomy for stage i seminoma of the testis
-
von der Maase H, Specht L, Jacobsen GK, Jakobsen A, Madsen EL, Pedersen M, et al. Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer 1993;29A:1931-1934
-
(1993)
Eur J Cancer
, vol.29 A
, pp. 1931-1934
-
-
Von Der Maase, H.1
Specht, L.2
Jacobsen, G.K.3
Jakobsen, A.4
Madsen, E.L.5
Pedersen, M.6
-
27
-
-
0026523482
-
Surveillance following orchidectomy for stage i testicular seminoma
-
Horwich A, Alsanjari N, A'Hern R, Nicholls J, Dearnaley DP, Fisher C. Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 1992;65:775-778
-
(1992)
Br J Cancer
, vol.65
, pp. 775-778
-
-
Horwich, A.1
Alsanjari, N.2
A'Hern, R.3
Nicholls, J.4
Dearnaley, D.P.5
Fisher, C.6
-
29
-
-
0036779798
-
Surveillance in stage i testicular seminoma-risk of late relapse
-
Chung P, Parker C, Panzarella T, Gospodarowicz MK, Jewett S, Milosevic MF, et al. Surveillance in stage I testicular seminoma-risk of late relapse. Can J Urol 2002;9:1637-1640
-
(2002)
Can J Urol
, vol.9
, pp. 1637-1640
-
-
Chung, P.1
Parker, C.2
Panzarella, T.3
Gospodarowicz, M.K.4
Jewett, S.5
Milosevic, M.F.6
-
30
-
-
13844280925
-
Long-term outcome of postorchiectomy surveillance for Stage i testicular seminoma
-
Choo R, Thomas G, Woo T, Lee D, Kong B, Iscoe N, et al., Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma. Int J Radiat Oncol Biol Phys 2005;61:736-740
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.61
, pp. 736-740
-
-
Choo, R.1
Thomas, G.2
Woo, T.3
Lee, D.4
Kong, B.5
Iscoe, N.6
-
31
-
-
0029842644
-
Adjuvant radiation versus observation: A cost analysis of alternate management schemes in early-stage testicular seminoma
-
Sharda NN, Kinsella TJ, Ritter MA. Adjuvant radiation versus observation: A cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol 1996;14:2933-2939
-
(1996)
J Clin Oncol
, vol.14
, pp. 2933-2939
-
-
Sharda, N.N.1
Kinsella, T.J.2
Ritter, M.A.3
-
32
-
-
74649085679
-
No role for routine chest radiography in stage i seminoma surveillance
-
Tolan S, Vesprini D, Jewett MA, Warde PR, O'Malley M, Panzarella T, et al. No role for routine chest radiography in stage I seminoma surveillance. Eur Urol 2010;57:474-479
-
(2010)
Eur Urol
, vol.57
, pp. 474-479
-
-
Tolan, S.1
Vesprini, D.2
Jewett, M.A.3
Warde, P.R.4
O'Malley, M.5
Panzarella, T.6
-
33
-
-
0028198505
-
Pilot studies of 2 and 1 course carboplatin as adjuvant for stage i seminoma: Should it be tested in a randomized trial against radiotherapy?
-
Oliver RT, Edmonds PM, Ong JY, Ostrowski MJ, Jackson AW, Baille- Johnson H, et al. Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys 1994;29:3-8.
-
(1994)
Int J Radiat Oncol Biol Phys
, vol.29
, pp. 3-8
-
-
Oliver, R.T.1
Edmonds, P.M.2
Ong, J.Y.3
Ostrowski, M.J.4
Jackson, A.W.5
Baille- Johnson, H.6
-
34
-
-
33644660123
-
Risk-adapted management for patients with clinical stage i seminoma: The Second Spanish Germ Cell Cancer Cooperative Group study
-
Aparicio J, Germà JR, García del Muro X, Maroto P, Arranz JA, Sáenz A, et al. Risk-adapted management for patients with clinical stage I seminoma: The Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol 2005;23:8717-8723
-
(2005)
J Clin Oncol
, vol.23
, pp. 8717-8723
-
-
Aparicio, J.1
Germà, J.R.2
García Del Muro, X.3
Maroto, P.4
Arranz, J.A.5
Sáenz, A.6
-
35
-
-
44949179724
-
Evidence-based pragmatic guidelines for the follow-up of testicular cancer: Optimising the detection of relapse
-
van As NJ, Gilbert DC, Money-Kyrle J, Bloomfield D, Beesley S, Dearnaley DP, et al. Evidence-based pragmatic guidelines for the follow-up of testicular cancer: Optimising the detection of relapse. Br J Cancer 2008;98:1894-1902
-
(2008)
Br J Cancer
, vol.98
, pp. 1894-1902
-
-
Van As, N.J.1
Gilbert, D.C.2
Money-Kyrle, J.3
Bloomfield, D.4
Beesley, S.5
Dearnaley, D.P.6
-
36
-
-
36549007486
-
Computed tomography: An increasing source of radiation exposure
-
Brenner DJ, Hall EJ. Computed tomography: An increasing source of radiation exposure. N Engl J Med 2007;357:2277-2284
-
(2007)
N Engl J Med
, vol.357
, pp. 2277-2284
-
-
Brenner, D.J.1
Hall, E.J.2
-
37
-
-
0036321566
-
Long-term experience with carboplatin monotherapy for clinical stage i seminoma: A retrospective single-center study
-
Steiner H, Höltl L, Wirtenberger W, Berger AP, Bartsch G, Hobisch A, et al. Long-term experience with carboplatin monotherapy for clinical stage I seminoma: A retrospective single-center study. Urology 2002;60:324-328
-
(2002)
Urology
, vol.60
, pp. 324-328
-
-
Steiner, H.1
Höltl, L.2
Wirtenberger, W.3
Berger, A.P.4
Bartsch, G.5
Hobisch, A.6
-
38
-
-
0030985234
-
Phase II study: Adjuvant single-agent carboplatin therapy for clinical stage i seminoma
-
Krege S, Kalund G, Otto T, Goepel M, Rübben H, Phase II study: Adjuvant single-agent carboplatin therapy for clinical stage I seminoma. Eur Urol 1997;31:405-407
-
(1997)
Eur Urol
, vol.31
, pp. 405-407
-
-
Krege, S.1
Kalund, G.2
Otto, T.3
Goepel, M.4
Rübben, H.5
-
39
-
-
0035151394
-
Twelve-year experience with two courses of adjuvant singleagent carboplatin therapy for clinical stage i seminoma
-
Reiter WJ, Brodowicz T, Alavi S, Zielinski CC, Kozak W, Maier U, et al. Twelve-year experience with two courses of adjuvant singleagent carboplatin therapy for clinical stage I seminoma. J Clin Oncol 2001;19:101-104
-
(2001)
J Clin Oncol
, vol.19
, pp. 101-104
-
-
Reiter, W.J.1
Brodowicz, T.2
Alavi, S.3
Zielinski, C.C.4
Kozak, W.5
Maier, U.6
-
40
-
-
17544399759
-
Adjuvant treatment of clinical stage i seminoma: Is a single course of carboplatin sufficient?
-
Dieckmann KP, Brüggeboes B, Pichlmeier U, Küster J, Müllerleile U, Bartels H. Adjuvant treatment of clinical stage I seminoma: Is a single course of carboplatin sufficient? Urology 2000;55:102-106
-
(2000)
Urology
, vol.55
, pp. 102-106
-
-
Dieckmann, K.P.1
Brüggeboes, B.2
Pichlmeier, U.3
Küster, J.4
Müllerleile, U.5
Bartels, H.6
-
41
-
-
0024440650
-
Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
-
Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, et al. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989;7:1748-1756
-
(1989)
J Clin Oncol
, vol.7
, pp. 1748-1756
-
-
Calvert, A.H.1
Newell, D.R.2
Gumbrell, L.A.3
O'Reilly, S.4
Burnell, M.5
Boxall, F.E.6
-
42
-
-
0033521949
-
Risk of leukemia after platinum-based chemotherapy for ovarian cancer
-
Travis LB, Holowaty EJ, Bergfeldt K, Lynch CF, Kohler BA, Wiklund T, et al. Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med 1999;340:351-357
-
(1999)
N Engl J Med
, vol.340
, pp. 351-357
-
-
Travis, L.B.1
Holowaty, E.J.2
Bergfeldt, K.3
Lynch, C.F.4
Kohler, B.A.5
Wiklund, T.6
-
43
-
-
40149089203
-
The long-term risks of adjuvant carboplatin treatment for stage i seminoma of the testis
-
Powles T, Robinson D, Shamash J, Moller H, Tranter N, Oliver T. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 2008;19:443-447
-
(2008)
Ann Oncol
, vol.19
, pp. 443-447
-
-
Powles, T.1
Robinson, D.2
Shamash, J.3
Moller, H.4
Tranter, N.5
Oliver, T.6
-
45
-
-
0031982535
-
Management of stage II seminoma
-
Warde P, Gospodarowicz M, Panzarella T, Catton C, Sturgeon J, Moore M, et al. Management of stage II seminoma. J Clin Oncol 1998;16:290-294
-
(1998)
J Clin Oncol
, vol.16
, pp. 290-294
-
-
Warde, P.1
Gospodarowicz, M.2
Panzarella, T.3
Catton, C.4
Sturgeon, J.5
Moore, M.6
-
46
-
-
0028989157
-
Radiotherapy for stages i and II testicular seminoma: Results and morbidity in 238 patients
-
Vallis KA, Howard GC, Duncan W, Cornbleet MA, Kerr GR. Radiotherapy for stages I and II testicular seminoma: Results and morbidity in 238 patients. Br J Radiol 1995;68:400-405
-
(1995)
Br J Radiol
, vol.68
, pp. 400-405
-
-
Vallis, K.A.1
Howard, G.C.2
Duncan, W.3
Cornbleet, M.A.4
Kerr, G.R.5
-
47
-
-
0027972386
-
Radiation therapy for stage i and IIA testicular seminoma
-
Lai PP, Bernstein MJ, Kim H, Perez CA, Wasserman TH, Kucik NA. Radiation therapy for stage I and IIA testicular seminoma. Int J Radiat Oncol Biol Phys 1994;28:373-379
-
(1994)
Int J Radiat Oncol Biol Phys
, vol.28
, pp. 373-379
-
-
Lai, P.P.1
Bernstein, M.J.2
Kim, H.3
Perez, C.A.4
Wasserman, T.H.5
Kucik, N.A.6
-
48
-
-
0037445189
-
Radiotherapy for stages IIA/B testicular seminoma: Final report of a prospective multicenter clinical trial
-
Classen J, Schmidberger H, Meisner C, Souchon R, Sautter-Bihl ML, Sauer R, et al. Radiotherapy for stages IIA/B testicular seminoma: Final report of a prospective multicenter clinical trial. J Clin Oncol 2003;21:1101-1106
-
(2003)
J Clin Oncol
, vol.21
, pp. 1101-1106
-
-
Classen, J.1
Schmidberger, H.2
Meisner, C.3
Souchon, R.4
Sautter-Bihl, M.L.5
Sauer, R.6
-
49
-
-
0030770833
-
Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: A prospective multicenter study
-
Schmidberger H, Bamberg M, Meisner C, Classen J, Winkler C, Hartmann M, et al. Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: A prospective multicenter study. Int J Radiat Oncol Biol Phys 1997;39:321-326
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.39
, pp. 321-326
-
-
Schmidberger, H.1
Bamberg, M.2
Meisner, C.3
Classen, J.4
Winkler, C.5
Hartmann, M.6
-
50
-
-
0032756457
-
Radiotherapy for stages i and IIA/B testicular seminoma
-
Bamberg M, Schmidberger H, Meisner C, Classen J, Souchon R, Weinknecht S, et al. Radiotherapy for stages I and IIA/B testicular seminoma. Int J Cancer 1999;83:823-827
-
(1999)
Int J Cancer
, vol.83
, pp. 823-827
-
-
Bamberg, M.1
Schmidberger, H.2
Meisner, C.3
Classen, J.4
Souchon, R.5
Weinknecht, S.6
-
52
-
-
38949176745
-
European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
-
Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol 2008;53:497-513.
-
(2008)
Eur Urol
, vol.53
, pp. 497-513
-
-
Krege, S.1
Beyer, J.2
Souchon, R.3
Albers, P.4
Albrecht, W.5
Algaba, F.6
-
53
-
-
31544447508
-
Single agent carboplatin for CS IIA/B testicular seminoma: A phase II study of the German Testicular Cancer Study Group (GTCSG)
-
Krege S, Boergermann C, Baschek R, Hinke A, Pottek T, Kliesch S, et al. Single agent carboplatin for CS IIA/B testicular seminoma: A phase II study of the German Testicular Cancer Study Group (GTCSG). Ann Oncol 2006;17:276-280
-
(2006)
Ann Oncol
, vol.17
, pp. 276-280
-
-
Krege, S.1
Boergermann, C.2
Baschek, R.3
Hinke, A.4
Pottek, T.5
Kliesch, S.6
-
54
-
-
56749175245
-
Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: A Spanish Germ Cell Cancer Group Study
-
Garcia-del-Muro X, Maroto P, Gumà J, Sastre J, López Brea M, Arranz JA, et al. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: A Spanish Germ Cell Cancer Group Study. J Clin Oncol 2008;26:5416-5421
-
(2008)
J Clin Oncol
, vol.26
, pp. 5416-5421
-
-
Garcia-Del-Muro, X.1
Maroto, P.2
Gumà, J.3
Sastre, J.4
López Brea, M.5
Arranz, J.A.6
-
55
-
-
0035313844
-
Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: Comparison with radiotherapy treatment alone
-
Patterson H, Norman AR, Mitra SS, Nicholls J, Fisher C, Dearnaley DP, et al. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: Comparison with radiotherapy treatment alone. Radiother Oncol 2001;59:5-11.
-
(2001)
Radiother Oncol
, vol.59
, pp. 5-11
-
-
Patterson, H.1
Norman, A.R.2
Mitra, S.S.3
Nicholls, J.4
Fisher, C.5
Dearnaley, D.P.6
-
56
-
-
39049130140
-
Effect of radiotherapy volume and dose on secondary cancer risk in stage i testicular seminoma
-
Zwahlen DR, Martin JM, Millar JL, Schneider U. Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma. Int J Radiat Oncol Biol Phys 2008;70:853-858
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.70
, pp. 853-858
-
-
Zwahlen, D.R.1
Martin, J.M.2
Millar, J.L.3
Schneider, U.4
-
57
-
-
35348890176
-
Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer
-
van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2007;25:4370-4378
-
(2007)
J Clin Oncol
, vol.25
, pp. 4370-4378
-
-
Van Den Belt-Dusebout, A.W.1
De Wit, R.2
Gietema, J.A.3
Horenblas, S.4
Louwman, M.W.5
-
58
-
-
0031037241
-
International germ cell consensus classification: A prognostic factorbased staging system for metastatic germ cell cancers
-
International Germ Cell Cancer Collaborative Group
-
International Germ Cell Consensus Classification: A prognostic factorbased staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;15:594-603.
-
(1997)
J Clin Oncol
, vol.15
, pp. 594-603
-
-
-
59
-
-
0024555713
-
Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol
-
Einhorn LH, Williams SD, Loehrer PJ, Birch R, Drasga R, Omura G, et al. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol. J Clin Oncol 1989;7:387-391
-
(1989)
J Clin Oncol
, vol.7
, pp. 387-391
-
-
Einhorn, L.H.1
Williams, S.D.2
Loehrer, P.J.3
Birch, R.4
Drasga, R.5
Omura, G.6
-
60
-
-
0035868896
-
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in goodprognosis germ cell cancer: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council
-
de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Fosså SD, et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in goodprognosis germ cell cancer: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol 2001;19:1629-1640
-
(2001)
J Clin Oncol
, vol.19
, pp. 1629-1640
-
-
De Wit, R.1
Roberts, J.T.2
Wilkinson, P.M.3
De Mulder, P.H.4
Mead, G.M.5
Fosså, S.D.6
-
61
-
-
0031894195
-
Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: The Indian University experience
-
Saxman SB, Finch D, Gonin R, Einhorn LH. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: The Indian University experience. J Clin Oncol 1998;16:702-706
-
(1998)
J Clin Oncol
, vol.16
, pp. 702-706
-
-
Saxman, S.B.1
Finch, D.2
Gonin, R.3
Einhorn, L.H.4
-
62
-
-
0037445185
-
Quality of life in good prognosis patients with metastatic germ cell cancer: A prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20)
-
Fosså SD, de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, et al. Quality of life in good prognosis patients with metastatic germ cell cancer: A prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). J Clin Oncol 2003;21:1107-1118
-
(2003)
J Clin Oncol
, vol.21
, pp. 1107-1118
-
-
Fosså, S.D.1
De Wit, R.2
Roberts, J.T.3
Wilkinson, P.M.4
De Mulder, P.H.5
Mead, G.M.6
-
63
-
-
17744399298
-
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma: MRC Testicular Tumour Working Party
-
Horwich A, Oliver RT, Wilkinson PM, Mead GM, Harland SJ, Cullen MH, et al. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma: MRC Testicular Tumour Working Party. Br J Cancer 2000;83:1623-1629
-
(2000)
Br J Cancer
, vol.83
, pp. 1623-1629
-
-
Horwich, A.1
Oliver, R.T.2
Wilkinson, P.M.3
Mead, G.M.4
Harland, S.J.5
Cullen, M.H.6
-
64
-
-
4344704483
-
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: A pooled analysis of two randomized trials
-
Bokemeyer C, Kollmannsberger C, Stenning S, Hartmann JT, Horwich A, Clemm C, et al. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: A pooled analysis of two randomized trials. Br J Cancer 2004;91:683-687
-
(2004)
Br J Cancer
, vol.91
, pp. 683-687
-
-
Bokemeyer, C.1
Kollmannsberger, C.2
Stenning, S.3
Hartmann, J.T.4
Horwich, A.5
Clemm, C.6
-
65
-
-
0037250290
-
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumors
-
O'Sullivan JM, Huddart RA, Norman AR, Nicholls J, Dearnaley DP, Horwich A. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumors. Ann Oncol 2003;14:91-96
-
(2003)
Ann Oncol
, vol.14
, pp. 91-96
-
-
O'Sullivan, J.M.1
Huddart, R.A.2
Norman, A.R.3
Nicholls, J.4
Dearnaley, D.P.5
Horwich, A.6
-
66
-
-
34447341196
-
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: A randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)
-
Culine S, Kerbrat P, Kramar A, Théodore C, Chevreau C, Geoffrois L, et al. Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: A randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP). Ann Oncol 2007;18:917-924
-
(2007)
Ann Oncol
, vol.18
, pp. 917-924
-
-
Culine, S.1
Kerbrat, P.2
Kramar, A.3
Théodore, C.4
Chevreau, C.5
Geoffrois, L.6
-
67
-
-
0035836014
-
Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: A randomized trial
-
Toner GC, Stockler MR, Boyer MJ, Jones M, Thomson DB, Harvey VJ, et al. Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: A randomized trial. Lancet 2001;357:739-745
-
(2001)
Lancet
, vol.357
, pp. 739-745
-
-
Toner, G.C.1
Stockler, M.R.2
Boyer, M.J.3
Jones, M.4
Thomson, D.B.5
Harvey, V.J.6
-
68
-
-
0031681280
-
Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: A randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group
-
European Organization for Research and Treatment of Cancer
-
de Wit R, Stoter G, Sleijfer DT, Neijt JP, ten Bokkel Huinink WW, de Prijck L, et al. Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: A randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer. Br J Cancer 1998;78:828-832
-
(1998)
Br J Cancer
, vol.78
, pp. 828-832
-
-
De Wit, R.1
Stoter, G.2
Sleijfer, D.T.3
Neijt, J.P.4
Ten Bokkel Huinink, W.W.5
De Prijck, L.6
-
69
-
-
0031950313
-
Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study
-
Nichols CR, Catalano PJ, Crawford ED, Vogelzang NJ, Einhorn LH, Loehrer PJ. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. J Clin Oncol 1998;16:1287-1293
-
(1998)
J Clin Oncol
, vol.16
, pp. 1287-1293
-
-
Nichols, C.R.1
Catalano, P.J.2
Crawford, E.D.3
Vogelzang, N.J.4
Einhorn, L.H.5
Loehrer, P.J.6
-
70
-
-
0030050024
-
Hematopoietic growth factors and treatment of testicular cancer: Biological interactions, routine use and dose-intensive chemotherapy
-
Bokemeyer C, Kuczyk MA, Köhne H, Einsele H, Kynast B, Schmoll HJ. Hematopoietic growth factors and treatment of testicular cancer: Biological interactions, routine use and dose-intensive chemotherapy. Ann Hematol 1996;72:1-9.
-
(1996)
Ann Hematol
, vol.72
, pp. 1-9
-
-
Bokemeyer, C.1
Kuczyk, M.A.2
Köhne, H.3
Einsele, H.4
Kynast, B.5
Schmoll, H.J.6
-
71
-
-
0030973965
-
Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma
-
Miller KD, Loehrer PJ, Gonin R, Einhorn LH, Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma. J Clin Oncol 1997;15:1427-1431
-
(1997)
J Clin Oncol
, vol.15
, pp. 1427-1431
-
-
Miller, K.D.1
Loehrer, P.J.2
Gonin, R.3
Einhorn, L.H.4
-
72
-
-
0036137584
-
Salvage chemotherapy for patients with advanced pure seminoma
-
Vuky J, Tickoo SK, Sheinfeld J, Bacik J, Amsterdam A, Mazumdar M, et al. Salvage chemotherapy for patients with advanced pure seminoma. J Clin Oncol 2002;20:297-301.
-
(2002)
J Clin Oncol
, vol.20
, pp. 297-301
-
-
Vuky, J.1
Tickoo, S.K.2
Sheinfeld, J.3
Bacik, J.4
Amsterdam, A.5
Mazumdar, M.6
-
73
-
-
33644830849
-
Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors
-
Kondagunta GV, Bacik J, Bajorin D, Dobrzynski D, Sheinfeld J, Motzer RJ, et al. Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors. J Clin Oncol 2005;23:9290-9294
-
(2005)
J Clin Oncol
, vol.23
, pp. 9290-9294
-
-
Kondagunta, G.V.1
Bacik, J.2
Bajorin, D.3
Dobrzynski, D.4
Sheinfeld, J.5
Motzer, R.J.6
-
74
-
-
0344734200
-
Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor
-
Loehrer PJ Sr, Gonin R, Nichols CR, Weathers T, Einhorn LH. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 1998;16:2500-2504
-
(1998)
J Clin Oncol
, vol.16
, pp. 2500-2504
-
-
Loehrer Sr., P.J.1
Gonin, R.2
Nichols, C.R.3
Weathers, T.4
Einhorn, L.H.5
-
75
-
-
34547200072
-
High-dose chemotherapy and stem-cell rescue for metastatic germcell tumors
-
Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R. High-dose chemotherapy and stem-cell rescue for metastatic germcell tumors. N Engl J Med 2007;357:340-348
-
(2007)
N Engl J Med
, vol.357
, pp. 340-348
-
-
Einhorn, L.H.1
Williams, S.D.2
Chamness, A.3
Brames, M.J.4
Perkins, S.M.5
Abonour, R.6
-
76
-
-
25144455744
-
A randomized trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumors
-
Pico JL, Rosti G, Kramar A, Wandt H, Koza V, Salvioni R, et al. A randomized trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumors. Ann Oncol 2005;16:1152-1159
-
(2005)
Ann Oncol
, vol.16
, pp. 1152-1159
-
-
Pico, J.L.1
Rosti, G.2
Kramar, A.3
Wandt, H.4
Koza, V.5
Salvioni, R.6
-
77
-
-
0036242756
-
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: A matched-pair analysis
-
Beyer J, Stenning S, Gerl A, Fossa S, Siegert W. High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis. Ann Oncol 2002;13:599-605.
-
(2002)
Ann Oncol
, vol.13
, pp. 599-605
-
-
Beyer, J.1
Stenning, S.2
Gerl, A.3
Fossa, S.4
Siegert, W.5
-
78
-
-
3142577828
-
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group
-
Kollmannsberger C, Beyer J, Liersch R, Schoeffski P, Metzner B, Hartmann JT, et al. Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group. J Clin Oncol 2004;22:108-114
-
(2004)
J Clin Oncol
, vol.22
, pp. 108-114
-
-
Kollmannsberger, C.1
Beyer, J.2
Liersch, R.3
Schoeffski, P.4
Metzner, B.5
Hartmann, J.T.6
-
79
-
-
0036534301
-
Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Cooperative Oncology Group
-
Hinton S, Catalano P, Einhorn LH, Loehrer PJ Sr, Kuzel T, Vaughn D, et al. Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2002;20:1859-1863.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1859-1863
-
-
Hinton, S.1
Catalano, P.2
Einhorn, L.H.3
Loehrer Sr., P.J.4
Kuzel, T.5
Vaughn, D.6
-
80
-
-
0033015208
-
Phase II trial of gemcitabine in refractory germ cell tumors
-
Einhorn LH, Stender MJ, Williams SD. Phase II trial of gemcitabine in refractory germ cell tumors. J Clin Oncol 1999;17:509-511
-
(1999)
J Clin Oncol
, vol.17
, pp. 509-511
-
-
Einhorn, L.H.1
Stender, M.J.2
Williams, S.D.3
-
81
-
-
0031041878
-
Residual mass following chemotherapy of seminoma
-
Horwich A, Paluchowska B, Norman A, Huddart R, Nicholls J, Fisher C, et al. Residual mass following chemotherapy of seminoma. Ann Oncol 1997;8:37-40.
-
(1997)
Ann Oncol
, vol.8
, pp. 37-40
-
-
Horwich, A.1
Paluchowska, B.2
Norman, A.3
Huddart, R.4
Nicholls, J.5
Fisher, C.6
-
82
-
-
0031894725
-
Early stage and advanced seminoma: Role of radiation therapy, surgery, and chemotherapy
-
Gospodarwicz MK, Sturgeon JF, Jewett MA. Early stage and advanced seminoma: Role of radiation therapy, surgery, and chemotherapy. Semin Oncol 1998;25:160-173
-
(1998)
Semin Oncol
, vol.25
, pp. 160-173
-
-
Gospodarwicz, M.K.1
Sturgeon, J.F.2
Jewett, M.A.3
-
83
-
-
0021888230
-
Advanced seminoma: Treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8)
-
Peckham MJ, Horwich A, Hendry WF. Advanced seminoma: Treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). Br J Cancer 1985;52:7-13.
-
(1985)
Br J Cancer
, vol.52
, pp. 7-13
-
-
Peckham, M.J.1
Horwich, A.2
Hendry, W.F.3
-
84
-
-
0036837270
-
Management of postchemotherapy residual masses in advanced seminoma
-
Flechon A, Bompas E, Biron P, Droz JP. Management of postchemotherapy residual masses in advanced seminoma. J Urol 2002;168:1975-1979
-
(2002)
J Urol
, vol.168
, pp. 1975-1979
-
-
Flechon, A.1
Bompas, E.2
Biron, P.3
Droz, J.P.4
-
85
-
-
27744481919
-
Postchemotherapy residual masses in advanced seminoma: Current management and outcomes
-
Quek ML, Simma-Chiang V, Stein JP, Pinski J, Quinn DI, Skinner DG. Postchemotherapy residual masses in advanced seminoma: Current management and outcomes. Expert Rev Anticancer Ther 2005;5:869-874
-
(2005)
Expert Rev Anticancer Ther
, vol.5
, pp. 869-874
-
-
Quek, M.L.1
Simma-Chiang, V.2
Stein, J.P.3
Pinski, J.4
Quinn, D.I.5
Skinner, D.G.6
-
86
-
-
0030863030
-
Vena caval resection for bulky metastatic germ cell tumors: An 18-year experience
-
Spitz A, Wilson TG, Kawachi MH, Ahlering TE, Skinner DG. Vena caval resection for bulky metastatic germ cell tumors: An 18-year experience. J Urol 1997;158:1813-1818
-
(1997)
J Urol
, vol.158
, pp. 1813-1818
-
-
Spitz, A.1
Wilson, T.G.2
Kawachi, M.H.3
Ahlering, T.E.4
Skinner, D.G.5
-
87
-
-
0038626293
-
Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
-
Mosharafa AA, Foster RS, Leibovich BC, Bihrle R, Johnson C, Donohue JP. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol 2003;169:2126-2128
-
(2003)
J Urol
, vol.169
, pp. 2126-2128
-
-
Mosharafa, A.A.1
Foster, R.S.2
Leibovich, B.C.3
Bihrle, R.4
Johnson, C.5
Donohue, J.P.6
-
88
-
-
0022003196
-
Therapeutic guidelines and results in advanced seminoma
-
Friedman EL, Garnick MB, Stomper PC, Mauch PM, Harrington DP, Richie JP. Therapeutic guidelines and results in advanced seminoma. J Clin Oncol 1985;3:1325-1332
-
(1985)
J Clin Oncol
, vol.3
, pp. 1325-1332
-
-
Friedman, E.L.1
Garnick, M.B.2
Stomper, P.C.3
Mauch, P.M.4
Harrington, D.P.5
Richie, J.P.6
-
89
-
-
0023684329
-
Treatment of the residual retroperitoneal mass after chemotherapy for advanced seminoma
-
Ellison MF, Mostofi FK, Flanigan RC. Treatment of the residual retroperitoneal mass after chemotherapy for advanced seminoma. J Urol 1988;140:618-620
-
(1988)
J Urol
, vol.140
, pp. 618-620
-
-
Ellison, M.F.1
Mostofi, F.K.2
Flanigan, R.C.3
-
90
-
-
0024389846
-
Simple nontoxic treatment of advanced metastatic seminoma with carboplatin
-
Horwich A, Dearnaley DP, Duchesne GM, Williams M, Brada M, Peckham MJ. Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol 1989;7:1150-1156
-
(1989)
J Clin Oncol
, vol.7
, pp. 1150-1156
-
-
Horwich, A.1
Dearnaley, D.P.2
Duchesne, G.M.3
Williams, M.4
Brada, M.5
Peckham, M.J.6
-
91
-
-
0032956255
-
The management of residual masses after chemotherapy in metastatic seminoma
-
Ravi R, Ong J, Oliver RT, Badenoch DF, Fowler CG, Hendry WF. The management of residual masses after chemotherapy in metastatic seminoma. BJU Int 1999;83:649-653
-
(1999)
BJU Int
, vol.83
, pp. 649-653
-
-
Ravi, R.1
Ong, J.2
Oliver, R.T.3
Badenoch, D.F.4
Fowler, C.G.5
Hendry, W.F.6
-
92
-
-
9044243757
-
Management of residual mass in advanced seminoma: Results and recommendations from the Memorial Sloan-Kettering Cancer Center
-
Puc HS, Heelan R, Mazumdar M, Herr H, Scheinfeld J, Vlamis V, et al. Management of residual mass in advanced seminoma: Results and recommendations from the Memorial Sloan-Kettering Cancer Center. J Clin Oncol 1996;14:454-460
-
(1996)
J Clin Oncol
, vol.14
, pp. 454-460
-
-
Puc, H.S.1
Heelan, R.2
Mazumdar, M.3
Herr, H.4
Scheinfeld, J.5
Vlamis, V.6
-
93
-
-
0023198254
-
Residual mass after chemotherapy for seminoma: Changing concepts of management
-
Herr HW, Bosl G. Residual mass after chemotherapy for seminoma: Changing concepts of management. J Urol 1987;137:1234-1235
-
(1987)
J Urol
, vol.137
, pp. 1234-1235
-
-
Herr, H.W.1
Bosl, G.2
-
94
-
-
39149113090
-
The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma
-
Hinz S, Schrader M, Kempkensteffen C, Bares R, Brenner W, Krege S, et al. The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. J Urol 2008;179:936-940
-
(2008)
J Urol
, vol.179
, pp. 936-940
-
-
Hinz, S.1
Schrader, M.2
Kempkensteffen, C.3
Bares, R.4
Brenner, W.5
Krege, S.6
-
95
-
-
1842509872
-
2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: An update of the prospective multicentric SEMPET trial
-
De Santis M, Becherer A, Bokemeyer C, Stoiber F, Oechsle K, Sellner F, et al. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: An update of the prospective multicentric SEMPET trial. J Clin Oncol 2004;22:1034-1039
-
(2004)
J Clin Oncol
, vol.22
, pp. 1034-1039
-
-
De Santis, M.1
Becherer, A.2
Bokemeyer, C.3
Stoiber, F.4
Oechsle, K.5
Sellner, F.6
-
96
-
-
0032728818
-
Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma
-
Ganjoo KN, Chan RJ, Sharma M, Einhorn LH. Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma. J Clin Oncol 1999;17:3457-3460
-
(1999)
J Clin Oncol
, vol.17
, pp. 3457-3460
-
-
Ganjoo, K.N.1
Chan, R.J.2
Sharma, M.3
Einhorn, L.H.4
-
97
-
-
20244368226
-
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals
-
Becherer A, De Santis M, Karanikas G, Szabó M, Bokemeyer C, Dohmen BM, et al. FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals. Eur J Radiol 2005;54:284-288
-
(2005)
Eur J Radiol
, vol.54
, pp. 284-288
-
-
Becherer, A.1
De Santis, M.2
Karanikas, G.3
Szabó, M.4
Bokemeyer, C.5
Dohmen, B.M.6
-
98
-
-
18144447926
-
Radiotherapy after chemotherapy for metastatic seminoma: A diminishing role, MRC Testicular Tumour Working Party
-
Duchesne GM, Stenning SP, Aass N, Mead GM, Fosså SD, Oliver RT, et al. Radiotherapy after chemotherapy for metastatic seminoma: A diminishing role, MRC Testicular Tumour Working Party. Eur J Cancer 1997;33:829-835
-
(1997)
Eur J Cancer
, vol.33
, pp. 829-835
-
-
Duchesne, G.M.1
Stenning, S.P.2
Aass, N.3
Mead, G.M.4
Fosså, S.D.5
Oliver, R.T.6
-
99
-
-
0038012184
-
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage i seminoma
-
Aparicio J, García del Muro X, Maroto P, Paz-Ares L, Alba E, Sáenz A, et al. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol 2003;14:867-872
-
(2003)
Ann Oncol
, vol.14
, pp. 867-872
-
-
Aparicio, J.1
García Del Muro, X.2
Maroto, P.3
Paz-Ares, L.4
Alba, E.5
Sáenz, A.6
-
100
-
-
0024580684
-
Radiation therapy of seminoma: 17-year experience at the Joint Center for Radiation Therapy
-
Lederman GS, Herman TS, Jochelson M, Silver BJ, Chaffey JT, Garnick MB, et al. Radiation therapy of seminoma: 17-year experience at the Joint Center for Radiation Therapy. Radiother Oncol 1989;14:203-208
-
(1989)
Radiother Oncol
, vol.14
, pp. 203-208
-
-
Lederman, G.S.1
Herman, T.S.2
Jochelson, M.3
Silver, B.J.4
Chaffey, J.T.5
Garnick, M.B.6
-
101
-
-
0026476291
-
Orchidectomy followed by radiotherapy in 176 stage i and II testicular seminoma patients: Benefits of a 10-year follow-up study
-
Bayens YC, Helle PA, Van Putten WL, Mali SP. Orchidectomy followed by radiotherapy in 176 stage I and II testicular seminoma patients: Benefits of a 10-year follow-up study. Radiother Oncol 1992;25:97-102.
-
(1992)
Radiother Oncol
, vol.25
, pp. 97-102
-
-
Bayens, Y.C.1
Helle, P.A.2
Van Putten, W.L.3
Mali, S.P.4
-
102
-
-
0030955107
-
Long-term evaluation of postorchiectomy radiotherapy for stage II seminoma
-
Whipple GL, Sagerman RH, van Rooy EM. Long-term evaluation of postorchiectomy radiotherapy for stage II seminoma. Am J Clin Oncol 1997;20:196-201.
-
(1997)
Am J Clin Oncol
, vol.20
, pp. 196-201
-
-
Whipple, G.L.1
Sagerman, R.H.2
Van Rooy, E.M.3
-
103
-
-
0032726796
-
Prognostic factors in seminomas with special respect to HCG: Results of a prospective multicenter study: Seminoma Study Group
-
Weissbach L, Bussar-Maatz R, Löhrs U, Schubert GE, Mann K, Hartmann M, et al. Prognostic factors in seminomas with special respect to HCG: Results of a prospective multicenter study: Seminoma Study Group. Eur Urol 1999;36:601-608
-
(1999)
Eur Urol
, vol.36
, pp. 601-608
-
-
Weissbach, L.1
Bussar-Maatz, R.2
Löhrs, U.3
Schubert, G.E.4
Mann, K.5
Hartmann, M.6
-
104
-
-
0025057840
-
Consensus statement on the investigation and management of testicular seminoma 1989
-
Thomas G, Jones W, VanOosterom A, Kawai T. Consensus statement on the investigation and management of testicular seminoma 1989. Prog Clin Biol Res 1990;357:285-294
-
(1990)
Prog Clin Biol Res
, vol.357
, pp. 285-294
-
-
Thomas, G.1
Jones, W.2
Vanoosterom, A.3
Kawai, T.4
|